Alphatec Spine Names New Chief Financial Officer
Most recently, Mr. Wulff served as Executive Vice President and ChiefFinancial Officer for Artes Medical, Inc. (Nasdaq: ARTE), a San Diego-basedmedical technology company. In that position, he assisted the company inraising over $120 million in capital, including successfully managing itsinitial public offering (IPO) on NASDAQ. In addition, he established aresponsive infrastructure to support the company's commercial development andU.S. market launch of its primary product.
Prior to joining Artes Medical, Mr. Wulff served in senior financepositions at both public and privately-held medical device and pharmaceuticalcompanies including CryoCor, Inc., Natural Alternatives International, Inc.,Epimmune Inc. and Ligand Pharmaceuticals Inc. While in these positions, inthe aggregate, he helped raise more than $250 million in equity and debtfinancing, completed M&A transactions valued at over $270 million, directedthe launch of commercial operations in Europe and orchestrated financialturnarounds and strategic collaborations.
"Peter Wulff will be a real asset for Alphatec," said Dirk Kuyper, thecompany's President and CEO. "He has an extremely strong background in themedical device industry and has built and directed operational infrastructureand financial reporting systems for both U.S. and international businesses.Peter's expertise will allow us to better manage our business as we seek tocontinue our growth and expansion of our operations."
Mr. Wulff immigrated to the U.S. from The Netherlands and earned a B.A. inboth Economics and Germanic Languages and an M.B.A. in Finance from IndianaUniversity. He is also a Certified Management Accountant.
About Alphatec Spine
Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings,Inc. (Nasdaq: ATEC). Alphatec Spine is a medical device company involved inthe design, development, manufacturing and marketing of products for thesurgical treatment of spine disorders, primarily focused on the aging spine.The company's mission is to combine world-class customer service withinnovative, surgeon-driven design that will help improve the aging patient'squality of life. The company is poised to achieve its goal through newsolutions for patients with osteoporosis and other aging spine deformities,improved minimally invasive products and techniques and integrated biologicssolutions. In addition to its U.S. operations, Alphatec Spine also marketsits spine products in Europe. In Asia, the company markets a broad line ofspine and orthopedic products through its subsidiary, Alphatec Pacific, Inc.For more information, please visit http://www.alphatecspine.com.
Forward Looking Statements
This press release may contain "forward-looking statements" within themeaning of the Private Securities Litigation Reform Act of 1995 that involverisks and uncertainty. Such statements are based on management's currentexpectations and are subject to a number of risks and uncertainties that couldcause actual results to differ materially from those described in theforward-looking statements. Alphatec cautions investors that there can be noassurance that actual results or business conditions will not differmaterially from those projected or suggested in such forward-lookingstatements as a result of various factors, including, but not limited to therisks detailed from time to time in Alphatec's SEC reports. Alphatec disclaimsany intention or obligation to update or revise any forward-lookingstatements, whether as a result of new informati
You May Also Like